Back to search results

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Gastric Neoplasms · Esophageal Cancer · Liver Cancer · Liver Metastasis · MSS-CRC · MSS · Gastric Adenocarcinoma · Peritoneal Cancer · Peritoneal Carcinoma · Peritoneal Metastases · MSI-H · Gastric Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • AHN West Penn Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Patrick Wagner, MD) · patrick.wagner@ahn.org · 412-359-3731
    Contact: Study coordinator (AHN Clinical Trial Contact) · clinicaltrials@ahn.org · 412-359-3731
    Contact: Principal Investigator (Patrick Wagner, MD)
    David Bartlett, MD (Sub-investigator)
    Albert Donnenberg, PhD (Sub-investigator)
    Casey Allen, MD (Sub-investigator)
    Yazan Samhouri, MD (Sub-investigator)
    Nathan Bahary, MD (Sub-investigator)
Study leads

  • Patrick Wagner, MD

    Principal Investigator

    Allegheny Health Network

View source on ClinicalTrials.gov(opens in a new tab)